CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 109 filers reported holding CYTOKINETICS INC in Q1 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $125,000 | -52.7% | 10,345 | -49.7% | 0.24% | -55.6% |
| Q1 2017 | $264,000 | +5.6% | 20,560 | 0.0% | 0.53% | +0.8% |
| Q4 2016 | $250,000 | -99.9% | 20,560 | +2.7% | 0.53% | +106.2% |
| Q3 2016 | $183,737,000 | +121580.1% | 20,015 | +25.6% | 0.26% | +107.3% |
| Q2 2016 | $151,000 | -99.8% | 15,930 | +13.8% | 0.12% | +100.0% |
| Q1 2016 | $98,700,000 | +110798.9% | 14,000 | +64.4% | 0.06% | +14.8% |
| Q4 2015 | $89,000 | -72.2% | 8,515 | -79.9% | 0.05% | -67.7% |
| Q3 2013 | $320,000 | +133.6% | 42,292 | +258.3% | 0.17% | +111.4% |
| Q2 2013 | $137,000 | – | 11,804 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |